Equity investment from leading brain-focused foundation will fund preclinical work required to begin human clinical trials. Toronto, Canada, April 10, 2023 – Bioelectronic medicine company Panaxium today announced that it has received an […]
Precision Directed
We imagine a future where permanent disability from brain injury no longer exists.
Modern neuroscience has discovered how the human brain can be intentionally rewired post-injury – but the tools do not exist yet.
1 in 3 people
will survive a stroke or traumatic brain injury in their lifetime – but still be left with life-altering disability.
Our Solution
Get In and Get Out.
We believe the purpose of the ultimate brain-machine interface is
to heal the human brain.
Panaxium’s precision therapy BMI platform is built for surgeons and neurologists to directly intervene, treat the injury, and leave the patient to return to a life of normalcy.
Panaxium’s precision therapy BMI platform is built for surgeons and neurologists to directly intervene, treat the injury, and leave the patient to return to a life of normalcy.
An up close approach
Iontronic interface safely & selectively “speaks” the language of cells to direct precision healing.
It’s not just about the hardware: Precision healing requires advanced understanding of an injury
Panaxium’s proprietary MRI protocol & AI-assisted analysis
generates complete patient-specific representations of entire
functional networks.
This identifies specific disruption from damage, predicts natural
recovery, and aids planning for the implantation.
Together these technologies will enable the ultimate therapy: turning everyday activities into assisted recovery exercises.
In the OR, faster
Partnership with Synaptive Medical
Unlocking the ultimate brain-machine interface neuro-recovery therapy is not just about the device itself. It requires the ability to assess, plan, and strategize a personalized functional remapping to every patient’s specific injury.
Recent News
Panaxium Presents Brain Machine Interface Precision Neurostimulation Therapy at 2023 Ontario Bioscience Innovation Organization (OBIO) Investment Summit
Panaxium COO Jonathan Balfour presents novel brain machine interface device platform at OBIO Investment Summit 2023 in Toronto, Canada.
Dr. Gilles Huberfeld to Lead First In-Human Trial of Panaxium’s Next-Generation Brain Computer Interface
Dr. Gilles Huberfeld, MD, PhD, is leading the 1st humans patient investigations of Panaxium's next-generation iontronic brain computer interface in 2023 in Paris, France.
Panaxium Wins 1st Place Jury Prize at 2022 Brain Innovation Days
Panaxium won the 2022 Brain Innovation Days 1st Place Jury Prize at the conference’s pitch competition held in Brussels, Belgium, on October 12, 2022.
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR
Panaxium is excited to share a development partnership with Synaptive Medical
Panaxium to Present Novel Neural Interface Data at Asilomar Bioelectronic Symposium 2022
Interactive symposium with leading experts and rising stars in the field will focus on defining the frontiers of bioelectronics and mapping future directions.
IONBIKE RISE Project continues to produce collaborative research in the use of iongels for bioelectronics.
Panaxium is fortunate to share progress as an industry partner within the consortium of leading institutions in Iongel research
Professor Numa Dancause Joins Panaxium Therapy Development Team as Scientific Advisor and Pre-Clinical Collaborator
World-leader in cortical motor control research and Université de Montréal Professor is an expert in premotor cortex function and cortical plasticity following brain injury.
World-Renowned Bioelectronic Mechanisms Expert Rod O’Connor Joins Panaxium as Scientific Advisor
Bioelectronic medicine company developing comprehensive neuromodulation therapies to heal the damaged human brain.
Dr. Allen Waziri Joins Bioelectronic Medicine Company Panaxium SAS as Clinical Advisor
Practicing neurosurgeon and translational neuroscientist, Dr. Waziri, MD is the CEO and Co-Founder of Washington, DC-based iCE Neurosystems
FIDELGLIO – An inspiring research project that could lead to brain cancer treatments
Panaxium is proud to be recently selected as a research partner investigating bioelectronics for treating glioblastoma tumours
Bioelectronic Medicine Company Panaxium SAS Hiring Multidisciplinary Team of Scientists and Engineers to Commercialize Bioelectronic Medicine Treatments
New hires will join world-renowned researchers leading groundbreaking development of bioelectronics materials and novel electronic devices to treat chronic disease.
Bioelectronic Medicine Company Panaxium SAS To Open R&D Centre in France
Leading bioelectronics medicine company aims to leverage bioelectronics materials and devices to treat chronic disease.
Dr. Jonathan Rivnay Joins Bioelectronic Medicine Company Panaxium SAS as Scientific Advisor
NSF CAREER Award-winning Northwestern University biomedical engineer is developing new polymer-based bioelectronic materials that could enable next-generation diagnostic and therapeutic tools.
Dr. Dion Khodagholy Joins Bioelectronic Medicine Company Panaxium SAS as Scientific Advisor
Groundbreaking brain researcher and Columbia University Assistant Professor is developing novel electronic devices that allow efficient interaction with biological substrates.
Dr. George Malliaras and Dr. Róisín Owens Join Bioelectronic Medicine Company Panaxium SAS as Principal Scientific Advisors
World-renowned scientists leverage bioelectronics materials and devices to treat chronic disease.